Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025

  • Post author:
  • Post category:

Medicines containing semaglutide: PRAC investigating risk of rare eye conditionPRAC will assess risk of non-arteritic anterior ischemic optic neuropathy (NAION)EMA’s safety committee, PRAC, has started a review of medicines containing…

Continue ReadingMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025

  • Post author:
  • Post category:

CVMP opinions on veterinary medicinal productsThe Committee adopted by consensus a positive opinion for a marketing authorisation in exceptional circumstances for Bluevac-3 (Bluetongue virus, serotype 3, strain BTV-3/NET2023, inactivated) from…

Continue ReadingMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025